Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study-Reference-Cited by-同舟云学术

Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study

Published:2016-08 Issue:5 Volume:115 Page:542-548
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Sayasneh A,Ferrara L,De Cock B,Saso S,Al-Memar M,Johnson S,Kaijser J,Carvalho J,Husicka R,Smith A,Stalder C,Blanco M C,Ettore G,Van Calster B,Timmerman D,Bourne T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016227.pdf

Reference31 articles.

1. Bristow RE, Chang J, Ziogas A, Anton-Culver H (2013) Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 121 (6): 1226–1234.

2. Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H (2014) High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease. Gynecol Oncol 132 (2): 403–410.

3. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD PLCO Project Team (2011) Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305 (22): 2295–2303.

4. Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Brit J Obstet Gynacol 122 (3): 434–443.

5. Darai E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P (2013) Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 19 (2): 151–166.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two‐step strategy using benign descriptors and ADNEX model: Portuguese multicenter study;Ultrasound in Obstetrics & Gynecology;2024-09-04

2. Validation of ADNEX and IOTA two‐step strategy and estimation of risk of complications during follow‐up of adnexal masses in low‐risk population;Ultrasound in Obstetrics & Gynecology;2024-08-16

3. Validation of the IOTA ADNEX Model Among Japanese Women Performed by Gynecology Trainees and Ultrasound Specialists;Journal of Ultrasound in Medicine;2024-07-02

4. ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies;BMJ Medicine;2024-02

5. Artificial Intelligence in Ultrasound Diagnoses of Ovarian Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-01-19